Abstract
The negative impact of iron overload (IO) on outcomes of allogeneic hematopoietic cell transplantation (HCT) is well recognized, but its impact on umbilical cord blood (UCB) transplant outcome is unknown. We retrospectively analyzed outcomes of 150 patients who received UCB-HCT at our institution, stratified by pre-HCT serum ferritin (SF) level of 2000 ng/mL. Two-year overall survival rate among patients with SF >2000 and ≤2000 ng/mL was 26.1% (95% CI, 10.6% to 44.7%) and 52.1% (95% CI, 40.1% to 62.8%), respectively; hazard ratio (HR) = 2.26 (95% CI, 1.28 to 4.00, P = .005). Two-year nonrelapse mortality rate was higher among patients with SF >2000 ng/mL (56.5%; 95% CI, 33.3% to 74.4%) compared to SF ≤2000 ng/mL (30.1%; 95% CI, 20.0% to 40.9%); HR = 2.18 (95% CI, 1.10 to 4.31, P = .025). Neutrophil engraftment at 42 days was 78.3% (95% CI, 53.5% to 90.8%) in patients with SF >2000 ng/mL versus 91.8% (95% CI, 82.1% to 96.4%) in patients with SF ≤2000 ng/mL; HR = 0.58 (95% CI, 0.35 to 0.96, P = .034). A significant difference in platelet engraftment at 3 months was also observed: 52.2% (95% CI, 29.4% to 70.8%) for SF >2000 ng/mL versus 80.8% (95% CI, 69.5% to 88.3%) for SF ≤2000 ng/mL; HR = 0.48 (95% CI, 0.23 to 0.98, P = .044). ...Continue Reading
References
Oct 1, 1974·Transplantation·H GlucksbergE D Thomas
Aug 1, 1980·The American Journal of Medicine·H M ShulmanE D Thomas
May 31, 2001·British Journal of Haematology·L SahlstedtT Ruutu
Aug 15, 2002·Blood·John E WagnerStella M Davies
Jun 12, 2004·Blood·Neal FlomenbergDaniel Weisdorf
Nov 27, 2004·The New England Journal of Medicine·Mary J LaughlinMary M Horowitz
Feb 15, 2005·FEMS Immunology and Medical Microbiology·John J BullenCharles G Ward
Mar 2, 2005·Best Practice & Research. Clinical Haematology·Z Ioav CabantchikP Cianciulli
Jan 20, 2007·Blood·Philippe ArmandJoseph H Antin
Feb 6, 2007·Magnetic Resonance Imaging·Allard W OlthofMatthijs Oudkerk
Sep 3, 2008·Bone Marrow Transplantation·V PullarkatS J Forman
Feb 11, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sergio GiraltBrenda Sandmaier
Sep 20, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin WermkeUwe Platzbecker
Dec 25, 2012·International Journal of Hematology·Tatsunori GotoKoichi Miyamura
Mar 19, 2014·European Journal of Haematology·Hiroshi OkabeKeiya Ozawa
Apr 20, 2014·Blood·Philippe ArmandWael Saber
Sep 13, 2014·British Journal of Haematology·Ali T TaherMaria Domenica Cappellini
Nov 26, 2014·Lifetime Data Analysis·Jianing LiMei-Jie Zhang
Apr 12, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mohamed L SorrorMarcelo C Pasquini
May 15, 2015·Scientific Reports·Xiao ChaiMingfeng Zhao
Jan 23, 2016·European Journal of Haematology·Nicole Jacobi, Lena Herich
Oct 23, 2016·Clinical Lymphoma, Myeloma & Leukemia·Serdar SivginBulent Eser
May 16, 2017·Bone Marrow Transplantation·A OhmotoT Fukuda
Jun 7, 2017·Annals of Hematology·Annekathrin HilkenNicolaus Kröger
Jun 16, 2018·Haematologica·Xin JinMingfeng Zhao
Jul 7, 2018·Medicine·Zhengwei YanWei Wang
Citations
Mar 31, 2021·Bone Marrow Transplantation·Pavan TennetiMary Ann Knovich
Jul 19, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mary Ann Knovich
Apr 11, 2021·Transplantation and Cellular Therapy·Masaharu TamakiYoshinobu Kanda